Pulmonary and Cardiac Infections in Athletes

Clinics in Sports Medicine

Volumn 26, Issue 3, 2007, Pages 361-382

  Kruse, Roger J ^a,b   Cantor, Cathy L ^a,b  

^a TOLEDO HOSPITAL   (United States)

^b UNIVERSITY OF TOLEDO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMANTADINE; ANTIBIOTIC AGENT; ANTITUSSIVE AGENT; ANTIVIRUS AGENT; AZITHROMYCIN; BRONCHODILATING AGENT; CLARITHROMYCIN; COLCHICINE; COTRIMOXAZOLE; DECONGESTIVE AGENT; DIPHTHERIA PERTUSSIS TETANUS VACCINE; ERYTHROMYCIN; GENTAMICIN; IBUPROFEN; LIVE VACCINE; MACROLIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OSELTAMIVIR; PARACETAMOL; PENICILLIN G; RIMANTADINE; ZANAMIVIR;

BRONCHITIS; COMMUNITY ACQUIRED PNEUMONIA; COUGHING; DYSPNEA; ENDOCARDITIS; FEVER; HEADACHE; HEART DISEASE; HUMAN; INFLUENZA; LUNG INFECTION; MYALGIA; MYOCARDITIS; PERICARDITIS; PERTUSSIS; PNEUMONIA; REVIEW; RHEUMATIC FEVER; SINGLE DRUG DOSE; SPUTUM; THORAX PAIN;

ANTI-INFECTIVE AGENTS; HUMANS; MORBIDITY; MYOCARDITIS; PROGNOSIS; RESPIRATORY TRACT INFECTIONS; SPORTS; WORLD HEALTH;

EID: 34548417510     PISSN: 02785919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.csm.2007.04.002     Document Type: Review

References (136)

1. Baldwin D.R., and Macfarlane J.T. Community-acquired pneumonia. In: Cohen J., and Powderly W.G. (Eds). Cohen & Powderly: infectious diseases. 2nd edition (2004), Mosby, St. Louis (MO) 369-380
2. File Jr. T.M. The epidemiology of respiratory tract infections. Semin Respir Infect 15 (2000) 184-194
3. Bartlett J.G., Breiman R.F., and Mandell L.A. Community-acquired pneumonia in adults: guidelines for management. Clin Infect Dis 26 (1998) 811-838
4. Gleason P.P., Meehan T.P., Fine J.M., et al. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Intern Med 159 (1999) 2562-2572
5. Houck P.M., MacLehose R.F., Niederman M.S., et al. Empiric antibiotic therapy and mortality among Medicare pneumonia inpatients in 10 western states: 1993, 1995, and 1997. Chest 119 (2001) 1420-1426
6. Fine M.J., Smith M.A., Carson C.A., et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA 275 (1996) 134-141
7. Woodhead M.A., and Macfarlane J.T. Comparative clinical and laboratory features of legionella with pneumococcal and mycoplasma pneumonia. Br J Dis Chest 81 (1987) 133-139
8. Bartlett J.G., and Mundy L.M. Community acquired pneumonia. N Engl J Med 333 (1995) 1618-1624
9. Fraser D.W., Tsai T., Ornstein W., et al. Legionnaires' disease: description of an epidemic of pneumonia. N Engl J Med 297 (1977) 1189-1197
10. Mulazimoglu L., and Yu V.L. Can Legionnaires disease be diagnosed by clinical criteria? A critical review. Chest 120 (2001) 1049-1053
11. Yu V.L., Kroboth F.J., Shonnard J., et al. Legionnaires' disease: new clinical perspective from a prospective pneumonia study. Am J Med 73 (1982) 357-361
12. Marrie T.J. Community-acquired pneumonia. Clin Infect Dis 18 (1994) 501-515
13. Fine M.J., Hough L.J., Medsger A.R., et al. The hospital admission decision for patients with community-acquired pneumonia. Arch Intern Med 157 (1997) 36-44
14. Metlay J.P., Kapoor W.N., and Fine M.J. Does this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination. JAMA 278 (1997) 1440-1445
15. Mandell L.A., Bartlett J.G., Dowell S.F., et al. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 37 (2003) 1405-1433
16. Farr B.M., Sloman A.J., and Fisch M.J. Predicting death in patients hospitalized for community-acquired pneumonia. Ann Intern Med 115 (1991) 428-436
17. Fine M.J., Singer D.E., Hanusa B.H., et al. Validation of a pneumonia prognostic index using the MedisGroups Comparative Hospital Database. Am J Med 94 (1993) 153-159
18. Niederman M.S., Bass Jr. J.B., Campbell G.D., et al. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 148 (1993) 1418-1426
19. Niederman M.S., Mandell L.A., Anzueto A., et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 163 (2001) 1730-1754
20. File T.M. Community-acquired pneumonia. Lancet 362 (2003) 1991-2001
21. Boldy D.A., Skidmore S.J., and Ayres J.G. Acute bronchitis in the community: clinical features, infective factors, changes in pulmonary function and bronchial reactivity to histamine. Respir Med 84 (1990) 377-385
22. Williamson Jr. H.A. Pulmonary function tests in acute bronchitis: evidence for reversible airway obstruction. J Fam Pract 25 (1987) 251-256
23. Melbye H., Kongerud J., and Vorland L. Reversible airflow limitation in adults with respiratory infection. Eur Respir J 7 (1994) 1239-1245
24. Hueston W.J. A comparison of albuterol and erythromycin for the treatment of acute bronchitis. J Fam Pract 33 (1991) 476-480
25. Hueston W.J. Albuterol delivered by metered-dose inhaler to treat acute bronchitis. J Fam Pract 39 (1994) 437-440
26. Melbye H., Aasebo U., and Straume B. Symptomatic effect of inhaled fenoterol in acute bronchitis: a placebo-controlled double-blind study. Family Practice 8 (1991) 216-222
27. Metlay J.P., Schulz R., Li Y., et al. Influence of age on symptoms and presentation in patients with community acquired pneumonia. Arch Intern Med 157 13 (1997) 1453-1454
28. Braman S.S. Chronic cough due to chronic bronchitis: ACCP evidence-based clinical practice guidelines. Chest 129 (2006) 104S-115S
29. Anish E.J. Lower respiratory tract infections in adults. Clinics in Family Practice 6 1 (2004) 75-99
30. Mannino D., Homa D., Akinbami L., et al. Chronic obstructive pulmonary disease surveillance: United States, 1971-2000. MMWR Morb Mortal Wkly Rep 51 (2002) 1-13
31. Mannino D., Gagnon R., Petty T., et al. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 160 (2000) 1683-1689
32. Irwin R.S., Rosen M.J., and Braman S.S. Cough: a comprehensive review. Arch Intern Med 137 (1977) 1186-1191
33. Gonzales R., and Sande M.A. Uncomplicated acute bronchitis. Ann Intern Med 133 (2000) 981-991
34. Gwaltney J.M. Acute bronchitis. In: Mandel G.L., Bennett J.E., and Dolin R. (Eds). Mandell, Douglas, and Bennet's principles and practice of infectious diseases (2000), Churchill Livingstone, Philadelphia 703-706
35. Gonzales R., Steiner J.F., Lum A., et al. Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults. JAMA 281 (1999) 1512-1519
36. Irwin R.S., Curley F.J., and French C.L. Chronic cough. The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Am Rev Respir Dis 141 (1990) 640-647
37. Mello C.J., Irwin R.S., and Curley F.J. Predictive values of character, timing and complications of chronic cough in diagnosing its cause. Arch Intern Med 156 (1996) 997-1003
38. Evans A.S. Clinical syndromes in adults caused by respiratory infection. Med Clin North Am 51 (1967) 803-818
39. Heikkinen T., and Jarvinen A. The common cold. Lancet 361 (2003) 51-59
40. Snow V., Mottur-Pilson C., and Gonzales R. Principles of appropriate antibiotic use for treatment of acute bronchitis in adults. Ann Intern Med 134 (2001) 518-520
41. Gonzales R., Bartlett J.G., Besser R.E., et al. Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: background. Ann Intern Med 134 (2001) 521-529
42. Irwin R.S., Boulet L.P., and Cloutier M.M. Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest Physicians. Chest 114 (1998) 133S-181S
43. Cherry J.D. Epidemiological, clinical, and laboratory aspects of pertussis in adults. Clin Infect Dis 28 Suppl 2 (1999) S112-S117
44. Tozzi A.E., Celentano L.P., Atti M.L., et al. Diagnosis and management of pertussis. Can Med Assoc J 172 4 (2005) 509-515
45. Atkinson W. Epidemiology and prevention of vaccine preventable diseases (1996), Centers for Disease Control and Prevention, Atlanta (GA)
46. Bass J.W., Klenk E.L., Kotheimer J.B., et al. Antimicrobial treatment of pertussis. J Pediatr 75 (1969) 768-781
47. Mattoo S., and Cherry J.D. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 18 (2005) 326-382
48. Centers for Disease Control and Prevention. Guidelines for the control of pertussis outbreaks. 2000 (amendments made in 2005 and 2006). Available at: http://www.cdc.gov/nip/publications/pertussis/guide.htm. Accessed November 1, 2006.
49. Wright S.W., Edwards K.M., Decker M.D., et al. Pertussis infection in adults with persistent cough. JAMA 273 (1995) 1044-1046
50. Brown M.O., St. Anna L., and Ohl M. Clinical inquiries. What are the indications for evaluating a patient with cough for pertussis?. J Fam Pract 54 (2005) 74-76
51. Anonymous. Case definitions. Pertussis (whooping cough). Epidemiol Bull 20 (1999) 13-14
52. Muller F.M., Hoppe J.E., and Wirsing von Konig C.H. Laboratory diagnosis of pertussis: state of the art in 1997. J Clin Microbiol 35 (1997) 2435-2443
53. Hopkins R.S., Jajosky R.A., Hall P.A., et al. Centers for Disease Control and Prevention. Summary of notifiable diseases-United States, 2003. MMWR Morb Mortal Wkly Rep 52 (2005) 1-85
54. Roush S., Birkhead G., Koo D., et al. Mandatory reporting of diseases and conditions by health care professionals and laboratories. JAMA 282 (1999) 164-170
55. Bergquist S.O., Bernander S., and Dahnsjo H. Erythromycin in the treatment of pertussis: a study of bacteriologic and clinical effects. Pediatr Infect Dis J 6 (1987) 458-461
56. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 48 (1999) 1-28
57. Langley J.M., Halperin S.A., and Boucher F.D. Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis. Pediatrics 114 (2004) e96-e101
58. Aoyama T., Sunakawa K., and Iwata S. Efficacy of short-term treatment of pertussis with clarithromycin and azithromycin. J Pediatr 129 (1996) 761-764
59. Powell K.R., Baltimore R.S., Bernstein H.H., et al. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. Pediatrics 117 (2006) 965-978
60. Anonymous. Adacel and Boostrix: Tdap vaccines for adolescents and adults. Med Lett Drugs Ther 48 (2006) 5-6
61. Centers for Disease Control and Prevention. Recommended antimicrobial agents for treatment and postexposure prophylaxis of pertussis: 2005 CDC guidelines. MMWR Morb Mort Wkly Rep 54 RR-14 (2005) 1-16
62. Kerr J.R., and Preston N.W. Current pharmacotherapy of pertussis. Expert Opin Pharmacother 2 (2001) 1275-1282
63. Abramowicz M. The choice of antibacterial drugs. Med Lett Drugs Ther 43 (2001) 69-78
64. Smith N., Bresee J.S., Shay D.K., et al. Prevention and control of influenza: recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Recomm Rep 55 (2006) 1-42
65. Hayden F.G., Fritz R., Lobo M.C., et al. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest 101 (1998) 643-649
66. Hall C.B., and Douglas Jr. R.G. Nosocomial influenza infection as a cause of intercurrent fevers. Pediatrics 55 (1975) 673-677
67. Pope J.S., and Koenig S.M. Pulmonary disorders in the training room. Clin Sports Med 24 (2005) 541-564
68. Treanor J.J. Influenza virus. In: Mandell G.L., Bennett J.E., and Dolin R. (Eds). Principles and practice of infectious disease. 6th edition (2005), Churchill Livingstone, Philadelphia 2060-2078
69. Call S.A., Vollenweider M.A., Hornung C.A., et al. Does this patient have influenza?. JAMA 293 (2005) 987-997
70. Stiver G. The treatment of influenza with antiviral drugs. CMAJ 168 (2003) 49-56
71. Abramowicz M. Antiviral drugs for prophylaxis and treatment of influenza. Med Lett Drugs Ther 47 (2005) 93-95
72. Hayden F.G., Osterhaus A.D., Treanor J.J., et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. N Engl J Med 337 (1997) 874-880
73. Campion K., Silagy C., Cooper C., et al. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group. Lancet 352 (1998) 1877-1891
74. Nicholson K.G., Aoki F.Y., Osterhaus A.D.M.E., et al. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomized controlled trial. Lancet 355 (2000) 1845-1850
75. Waldman R.J., Hall W.N., McGee H., et al. Aspirin as a risk factor in Reye's syndrome. JAMA 247 (1982) 3089-3094
76. Hayden F.G. Influenza. In: Goldman L., and Ausiello D. (Eds). Cecil textbook of medicine. 22nd edition (2004), Saunders, St. Louis (MO) 1974-1987
77. Cooper N.J., Sutton A.J., Abrams K.R., et al. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomized controlled trials. BMJ 326 (2003) 1235-1242
78. Wynne J., Braunwald E., et al. The cardiomyopathies and myocarditides. In: Braunwald E., Fauci A., and Kasper D. (Eds). Harrison's principles of internal medicine. 15th edition (2001), McGraw Hill, New York 1359-1365
79. Feldman AMMcNamara D. Myocarditis. N Engl J Med 2000; 343:1388-98.
80. Bowles N.E., Ni J., Kearney D.L., et al. Detection of viruses in myocardial tissues by polymerase chain reaction. Evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 42 (2003) 466-472
81. Kuhl U., Pauschinger M., Seeberg B., et al. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 112 (2005) 1965-1970
82. See D.M., and Tilles J.G. Viral myocarditis. Rev Infect Dis 13 (1991) 951-956
83. Karjalainen J. Clinical diagnosis of myocarditis and dilated cardiomyopathy. Scand J Infect Dis 88 Suppl (1993) 33-43
84. Babuin L., and Jaffe A.S. Troponin: the biomarker of choice for the detection of cardiac injury. Can Med Assoc J 173 10 (2005) 1191-1202
85. Felker G.M., Boehmer J.P., Hruban R.H., et al. Echocardiographic findings in fulminant and acute myocarditis. J Am Coll Cardiol 36 (2000) 227-232
86. Gagliardi M.G., Bevilacqua M., Renzi P., et al. Usefulness of magnetic resonance imaging for diagnosis of acute myocarditis in infants and children, and comparison with endomyocardial biopsy. Am J Cardiol 68 (1991) 1089-1091
87. Marcu C.B., Beek A.M., and Van Rossum A.C. Clinical applications of cardiovascular magnetic resonance imaging. Can Med Assoc J 175 (2006) 911-917
88. O'Connell J.B., and Mason J.W. Diagnosing and treating active myocarditis. West J Med 150 (1989) 431-435
89. Mason J.E. Techniques for right and left ventricular endomyocardial biopsy. Am J Cardiol 41 (1978) 887-892
90. Abelmann W.H., Baim D.S., and Schnitt S.J. Endomyocardial biopsy: is it of clinical value?. Postgrad Med J 68 Suppl 1 (1992) S44-S46
91. Monrad E.S., Matsumori A., Murphy J.C., et al. Therapy with cyclosporine in experimental murine myocarditis with encephalomyocarditis virus. Circulation 73 (1986) 1058-1064
92. Tomioka N., Kishimoto C., Matsumori A., et al. Effects of prednisolone on acute viral myocarditis in mice. J Am Coll Cardiol 7 (1986) 868-872
93. Magnani J.W., and Dec G.W. Myocarditis: current trends in diagnosis and treatment. Circulation 113 (2006) 876-890
94. Remes J., Helin M., Vaino P., et al. Clinical outcome and left ventricular function 23 years after acute coxsackie virus myopericarditis. Eur Heart J 11 (1990) 182-188
95. Maron B.J., Zipes D.P., Ackerman M.J., et al. 36th Bethesda Conference: eligibility recommendations for competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol 45 (2005) 1313-1375
96. Braunwald E., et al. Pericardial disease. In: Braunwald E., Fauci A., and Kasper D. (Eds). Harrison's principles of internal medicine. 15th edition (2001), McGraw Hill, New York 1365-1372
97. Lange R.A., and Hillis D. Acute pericarditis. N Engl J Med 351 (2004) 2195-2201
98. Spodick D.H. Acute cardiac tamponade. N Engl J Med 349 (2003) 684-690
99. Zayas R., Anguita M., Torres F., et al. Incidence of specific etiology and role of methods for specific etiologic diagnosis of primary acute pericarditis. Am J Cardiol 75 (1995) 378-382
100. Permanyer-Miralda G., Sagrista-Sauleda J., and Soler-Soler J. Primary acute pericardial disease: a prospective series of 231 consecutive patients. Am J Cardiol 56 (1985) 623-630
101. Spodick D.H. Pericardial diseases. In: Braunwald E., Zipes D.P., and Libby P. (Eds). Heart disease, a textbook of cardiovascular medicine. 6th edition (2001), WB Saunders, Philadelphia 1823-1876
102. Troughton R.W., Asher C.R., and Klein A.L. Pericarditis. Lancet 363 (2004) 717-727
103. Lee T.H., et al. Chest discomfort and palpitations. In: Braunwald E., Fauci A., and Kasper D. (Eds). Harrison's principles of internal medicine. 15th edition (2001), McGraw Hill, New York 60-66
104. Spodick D.H. Acute pericarditis: current concepts and practice. JAMA 289 (2003) 1150-1153
105. Smith W.G. Coxsackie B myopericarditis in adults. Am Heart J 80 (1970) 34-46
106. Spodick D.H. Pericardial rub. Prospective, multiple observer investigation of pericardial friction in 100 patients. Am J Cardiol 35 (1975) 357-362
107. O'Rourke R.A., Braunwald E., et al. Physical examination of the cardiovascular system. In: Braunwald E., Fauci A., and Kasper D. (Eds). Harrison's principles of internal medicine. 15th edition (2001), McGraw Hill, New York 1255-1262
108. Bonnefoy E., Godon P., Kirkorian G., et al. Serum cardiac troponin I and ST-segment elevation in patients with acute pericarditis. Eur Heart J 21 (2000) 832-836
109. Permanyer-Miralda G. Acute pericardial disease: approach to the aetiologic diagnosis. Heart 90 (2004) 252-254
110. Shabetai R. Function of the pericardium. In: Fowler N.O. (Ed). The pericardium in health and disease (1985), Futura, Mount Kisco (NY) 19-50
111. Shabetai R. Acute pericarditis. Cardiol Clin 8 (1990) 639-644
112. Spodick D.H. Electrocardiogram in acute pericarditis. Distributions of morphologic and axial changes by stages. Am J Cardiol 33 (1974) 470-474
113. Cheitlin M.D., Alpert J.S., Armstrong W.F., et al. ACC/AHA guidelines for the clinical application of echocardiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography): developed in collaboration with the American Society of Echocardiography. Circulation 95 (1997) 1686-1744
114. Cheitlin M.D., Armstrong W.F., Aurigemma G.P., et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Circulation 108 (2003) 1146-1162
115. Imazio M., Demichelis B., Parrini I., et al. Day-hospital treatment of acute pericarditis: a management program for outpatient therapy. J Am Coll Cardiol 43 (2004) 1042-1046
116. Imazio M., Bobbio M., Cecchi E., et al. Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Arch Intern Med 165 (2005) 1987-1991
117. Carapetis J.R. Rheumatic fever. In: Cohen J., and Powderly W.G. (Eds). Cohen & Powderly: infectious diseases. 2nd edition (2004), Mosby, St. Louis (MO) 669-676
118. Dajanii A.S., Ayoub E., Bierman F.Z., et al. Guidelines for the diagnosis of rheumatic fever. Jones criteria, 1992 update. Special writing group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. JAMA 268 (1992) 2069-2073
119. Veasy L.G., Tani L.Y., and Hill H.R. Persistence of acute rheumatic fever in the intermountain area of the United States. J Pediatr 124 (1994) 9-16
120. Johnson D.R., Stevens D.L., and Kaplan E.L. Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. J Infect Dis 166 (1992) 374-382
121. Stollerman G.H. Rheumatogenic streptococci and autoimmunity. Clin Immunol Immunopathol 61 (1991) 131-142
122. Carapetis J.R., and Currie B.J. Rheumatic fever in a high-incidence population: the importance of monoarthritis and low-grade fever. Arch Dis Child 85 (2001) 223-227
123. Dajanii A.S., Bisno A.L., Chung K.J., et al. Special report on the prevention of rheumatic fever. A statement for health professionals by the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. Circulation 78 (1988) 1082-1086
124. Jones T.D. The diagnosis of rheumatic fever. JAMA 126 (1944) 481-484
125. Stollerman G.H., Markowitz M., Taranta A., et al. Jones criteria (revised) for guidance in the diagnosis of rheumatic fever. Circulation 32 (1965) 664-668
126. Stollerman G.H. Rheumatic fever. Lancet 349 (1997) 935-942
127. Anonymous. Rheumatic fever and rheumatic heart disease-report of a WHO study group. World Health Organization Technical Report Series (764) (1988), World Health Organization, Geneva (Switzerland) p. 1-58
128. Albert D.A., Harel L., and Karrison T. The treatment of rheumatic carditis: a review and meta-analysis. Medicine 74 (1995) 1-12
129. Gibofsky A., and Zabriskie J. Acute rheumatic fever and poststreptococcal arthritis. In: Harris E.D., Budd R.C., and Genovese M.C. (Eds). Kelley's textbook of rheumatology. 7th edition (2005), Saunders, St. Louis (MO) 1689-1695
130. Karchmer A.W., et al. Infective endocarditis. In: Braunwald E., Fauci A., and Kasper D. (Eds). Harrison's principles of internal medicine. 15th edition (2001), McGraw Hill, New York 809-820
131. Jalal S., Khan K.A., Alai M.S., et al. Clinical spectrum of infective endocarditis: 15 years experience. Indian Heart J 50 (1998) 516-519
132. Choudhury R., Grover A., Varma J., et al. Active infective endocarditis observed in an Indian hospital 1981-1991. Am J Cardiol 70 (1992) 1453-1458
133. Karchmer A.W. Infections of prosthetic heart valves. In: Waldvogel F., and Bisno A.L. (Eds). Infections associated with indwelling medical devices (2000), American Society for Microbiology, Washington, DC 145-172
134. Mylonakis E., and Calderwood S.B. Infective endocarditis in adults. N Engl J Med 345 (2001) 1318-1328
135. Baddour L.M., Wilson W.R., Bayer A.S., et al. AHA scientific statement on infective endocarditis-diagnosis, antimicrobial therapy, and management of complications. Circulation (2005) e394-e428
136. Durack D.T., Lukes A.S., Bright K.D., et al. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med 96 (1994) 200-209